GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Main Class | Sub Class | LM ID | Common Name ▼ | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
|---|---|---|---|---|---|---|---|---|---|
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/18:0)
|
1603.918527
|
C76H137N3O32
|
|||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/16:0)
|
1575.887227
|
C74H133N3O32
|
|||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/16:0)
|
1941.019426
|
C88H156N4O42
|
|||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/16:0)
|
1575.887227
|
C74H133N3O32
|
|||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen
|
GSG1170
|
||||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen
|
GSG1390
|
||||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen
|
|||||||
|
Neutral glycosphingolipids
|
Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series)
|
type I H antigen(d18:1/26:1(17Z))
|
1510.948703
|
C76H138N2O27
|
|||||
|
Neutral glycosphingolipids
|
Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series)
|
type I H antigen(d18:1/26:0)
|
1512.964353
|
C76H140N2O27
|
|||||
|
Neutral glycosphingolipids
|
Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series)
|
type I H antigen(d18:1/24:1(15Z))
|
1482.917403
|
C74H134N2O27
|
Displaying entries 101 - 110 of 6008 in total
To see the latest features, please visit our beta site.
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
